… made to find a treatment for COVID-19 patients. So far, … drugs have demonstrated some
efficacy on COVID-19 both in vitro and in animal models as well as in cases series. In COVID-19 …

… anti-rheumatic drugs (DMARDs) remain concerned about potential risks of severe COVID-19
outcomes. Meanwhile, several DMARDs have been proposed as COVID-19 therapies. …

… treatment available for COVID-19 and management is … and COVID-19 biology, several
drugs commonly used in rheumatology have been proposed as potential treatments for COVID-19…

… In addition to the use of specific antivirals, several drugs for … of antirheumatic drugs, including
immunomodulatory and immunosuppressive drugs, for the potential treatment of COVID-19, …

… of anti-rheumatic drugs in COVID-19. Ongoing research brings about hope for developing
evidence-based anti-rheumatic … efficient antiviral therapy for COVID-19. Despite the common …

… Which anti-rheumatic drugs can be used to treat COVID-19? … with COVID-19, out of 700
patients, no severe patient was under biological disease-modifying anti-rheumatic drugs [31]. …

… to modulate COVID-19-related hyperinflammation. This Review aims to summarise the
evidence on the use of antirheumatic drugs in the treatment of patients with COVID-19 from the …

… anti-rheumatic drugs may modulate inflammation and avoid a hyperinflammation that leads
to severe complications and death in subjects with COVID-19 [… whether anti-rheumatic drugs …

… of outpatients infected with COVID-19 who received antirheumatic disease therapies.
Finally… or harm with regard to COVID-19 mortality. Antirheumatic disease therapies should be …

… These drugs have been used in the management of coronavirus disease 2019 (COVID-19) …
the population-level interest in anti-rheumatic drugs during the COVID-19 era, by analyzing …